Prescription Required
Rapilif D 8mg/0.5mg Capsule is an effective medication designed to treat symptoms associated with benign prostatic hyperplasia (BPH) in men. This combination therapy contains two active ingredients: Silodosin (8mg) and Dutasteride (0.5mg). These two drugs work together to reduce the size of an enlarged prostate, alleviating symptoms like frequent urination, difficulty urinating, and urgency. By combining these medications, Rapilif D offers a comprehensive approach to treating BPH and improving the quality of life for affected men.
Liver disease can affect how your body processes Rapilif D. Since Dutasteride and Silodosin are metabolized in the liver, patients with liver conditions may require dose adjustments or an alternative treatment. Regular liver function tests are recommended for patients with liver issues.
Patients with kidney issues, particularly those with severe renal impairment, should use Rapilif D with caution. Silodosin may need to be adjusted or avoided in patients with kidney disease. Always inform your healthcare provider about any kidney conditions.
It is advisable to limit alcohol consumption while taking Rapilif D. Alcohol can exacerbate some side effects, such as dizziness, lightheadedness, and low blood pressure, which can be more pronounced when combined with Silodosin.
Rapilif D may cause dizziness or a feeling of lightheadedness, especially when standing up suddenly. This can impair your ability to drive or operate machinery safely. Use caution when performing such activities and consult your doctor if these symptoms occur.
Rapilif D is not recommended for women who are pregnant or planning to become pregnant. Dutasteride, one of the active ingredients in Rapilif D, may cause harm to a developing fetus. If you are pregnant, avoid handling the capsules to prevent exposure to Dutasteride.
Rapilif D should also be avoided by breastfeeding women. Both Silodosin and Dutasteride may pass into breast milk, potentially harming the infant. Speak to your doctor about alternatives if you are breastfeeding.
This medicine is a pharmaceutical preparation which has been prepared by combining two medicines: Silodosin and Dutasteride. Silodosin is an alpha receptor blocking ingredient that relaxes the muscles present around the bladder exit and prostate gland and facilitates urine to pass easily. Dutasteride is a 5-alpha reductase enzyme inhibitor that reduces the levels of the hormone that causes the prostate gland to enlarge by shrinking the prostate gland.
Benign prostatic hyperplasia (BPH) is a medical condition in which the prostate gland in men grows larger than normal and causes problems with urination like frequent urination or weak urine stream.
Store Rapilif D 8mg/0.5mg Capsule at room temperature (15°C to 30°C). Keep the capsules in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children.
Rapilif D 8mg/0.5mg Capsule is an effective treatment for benign prostatic hyperplasia (BPH). With its dual-action formula of Silodosin and Dutasteride, this medication provides both immediate relief from urinary symptoms and long-term benefits by reducing the size of the prostate. It's an essential medication for managing BPH and improving quality of life.
Content Updated on
Saturday, 1 March, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA